Treatment-Resistant Schizophrenia Biobank

The Treatment-Resistant Schizophrenia (TRS) Biobank includes cross-sectional data from more than 200 participants aged over 18, who contributed blood, neuroimaging, neuropsychological, and clinical information between 2012 and 2018. The Cooperative Research Centre (CRC) for Mental Health, working with the Melbourne Neuropsychiatry Centre (Department of Psychiatry, University of Melbourne), have collected data, biological samples and scanned brain images of participants with a diagnosis of schizophrenia, their family members, and healthy control participants to aid in the discovery of biomarkers in the future.